Dr. Ansstas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2008 - 2011
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2004 - 2007
University of Tichreen Faculty of MedicineClass of 2001
Bin Ziad High SchoolB.S., Science, 1992 - 1995
Certifications & Licensure
IL State Medical License 2018 - 2026
MO State Medical License 2007 - 2025
CA State Medical License 2020 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best Teaching Award Washington University School of Medicine, 2016
- Matthew Arquette Fellowship Achievement Award Washington University School of Medicine, 2010
- Internal Medicine Excellence Award St. Louis University, 2008
- Join now to see all
Clinical Trials
- Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis Start of enrollment: 2019 Oct 14
- Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma Start of enrollment: 2020 May 29
Publications & Presentations
PubMed
- 1 citationsA Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma.Jiayi Huang, Jian L Campian, Todd A DeWees, Zdenek Skrott, Martin Mistrik
International Journal of Radiation Oncology, Biology, Physics. 2024-11-01 - Recent Advancements in Cell-Based Therapies in Melanoma.George Nassief, Angela Anaeme, Karen Moussa, Abdallah N Mansour, George Ansstas
International Journal of Molecular Sciences. 2024-09-12 - A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, ...Brett G M Hughes, Alexander Guminski, Samantha Bowyer, Michael R Migden, Chrysalyne D Schmults
Journal of the American Academy of Dermatology. 2024-09-07
Journal Articles
- Pseudoprogression and Radiation Necrosis in Adult Brain Tumor Patients Treated With Proton Beam Radiation TherapyMarshall Meeks, BS, Sahaja Acharya, MD, Jiayi Huang, MD, Clifford Robinson, MD, Stephanie Perkins, MD, Michael Chicoine, MD, Jian Campian, MD, George Ansstas, MD, Alb..., Oncology (Williston Park), 1/11/2016
- Treatment with Tumor Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-refractory Recurrent Glioblastoma: A Case SeriesAnsstas G, Tran D, Case Rep Neurol, 1/1/2016
- Trends in utilization and impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: A review of the National Can...Jiayi Huang, Pamela Parker Samson, Stephanie Mabry Perkins, George Ansstas, Milan Chheda, Cliff Grant Robinson, Jian Li Campian, J Clin Oncol, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Rheumatoid arthritis presenting as pulmonary hypertension and vocal cord paralysis without joint manifestation in neurofibromatosis patient.George Ansstas, ACP Meeting, Missouri Chapter, 1/1/2008
- Recurrent respiratory papillomatosis as a cause of pulmonary cavitary lesions.Ali Pakravan, Yousef Assioun, George Ansstas, ACP Meeting, Missouri Chapter,, 1/1/2006
Lectures
- Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of Cetuximab in patients with metastatic/recurrent head and neck ...1/3/2011
- Decitabine For Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.1/4/2010
Other
- Gynecomastia, Review ArticleAnsstas,G, E-Medicine Online Publication
1/1/2012 - Factor inhibitor assay, Review ArticleAnsstas,G, E-Medicine Online Publication
1/1/2012 - Factor X, Review ArticleAnsstas,G, E-Medicine Online Publication
1/1/2012 - Join now to see all
Press Mentions
St. Louis Medical Experts Are Making Advances in Cancer CareAugust 14th, 2024
Arming Immune Foot Soldiers Against CancerMay 13th, 2020
NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Patients with Merkel Cell Carcinoma, Triple-Negative Breast Cancer and Solid TumorsNovember 27th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
